A Form 4 filed with the SEC on August 18, 2026, discloses that Kerrii B. Anderson, a director of Labcorp Holdings Inc. (NYSE:LH), sold 3,000 shares of common stock on August 17, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Shares sold: 3,000 shares of Labcorp Holdings Inc. common stock disposed of on August 17, 2026.
  • Sale price: $318.02 per share, as reported in the filing.
  • Post-transaction direct ownership: 6,563 shares of common stock held directly following the transaction.
  • Indirect holdings: 144 shares held indirectly by the Alexa M. Anderson Separate Trust and 144 shares held indirectly by the Cameron Taff Anderson Separate Trust.
  • Transaction code: "S" (sale), executed pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
  • Reporting person role: Kerrii B. Anderson is identified as a Director of the issuer.

Kerrii B. Anderson's Rule 10b5-1 Sale of Labcorp Common Stock

According to the filing, Kerrii B. Anderson, a director of Labcorp Holdings Inc., disposed of 3,000 shares of the company's common stock at a price of $318.02 per share on August 17, 2026. The filing notes that the transaction was carried out "pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended," a type of pre-arranged trading plan that allows insiders to sell shares at predetermined times or prices.

Following the reported sale, Anderson directly holds 6,563 shares of Labcorp common stock, according to the filing. In addition, the filing discloses two indirect ownership positions: 144 shares held by the Alexa M. Anderson Separate Trust and 144 shares held by the Cameron Taff Anderson Separate Trust, both reported as indirect beneficial ownership. No derivative securities transactions were reported in Table II of the filing.

The Form 4 was signed on August 18, 2026, by Kathryn W. Kyle as attorney-in-fact for Kerrii B. Anderson, and was filed that same date. The filing indicates the box was checked to confirm the transaction was made pursuant to a Rule 10b5-1(c) plan.

What Was Disclosed

The filing reports a single open-market sale of 3,000 shares of Labcorp Holdings Inc. common stock by director Kerrii B. Anderson at $318.02 per share on August 17, 2026, under a Rule 10b5-1 plan, leaving Anderson with 6,563 directly held shares.